ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Ohio » Neurology

Top Neurology Prescribers in Ohio

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RAYMOND BADDOUR MD

Neurology

9,315

$1M

543
252 are 65+

27%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 25%

$108
Average prescription price

Avg: $245

LUIS PAGANI MD

Neurology

8,311

$1.27M

419
84 are 65+

56%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$152
Average prescription price

Avg: $245

ROBERT BROCKER M.D.

Neurology

7,890

$1.03M

614
263 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

30%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$131
Average prescription price

Avg: $245

DANIEL JONES M.D.

Neurology

7,496

$1M

482
287 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$134
Average prescription price

Avg: $245

JOSEPH LA MANCUSA MD

Neurology

7,343

$1.61M

610
414 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$220
Average prescription price

Avg: $245

DENNIS SULLIVAN M.D.

Neurology

6,731

$1.61M

514
342 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$239
Average prescription price

Avg: $245

MARVIN RORICK MD

Neurology

6,708

$1.1M

493
271 are 65+

21%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 25%

$164
Average prescription price

Avg: $245

BRENDAN BAUER M.D.

Neurology

6,651

$1.12M

568
327 are 65+

19%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$168
Average prescription price

Avg: $245

WILLIAM BAUER MD, PHD

Neurology

6,632

$1.55M

320
101 are 65+

54%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$233
Average prescription price

Avg: $245

AHMAD ANOUTI M.D.

Neurology

6,534

$1.14M

540
257 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$174
Average prescription price

Avg: $245

HOLLY MAGGIANO MD

Neurology

6,465

$1.86M

555
325 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$287
Average prescription price

Avg: $245

JOSEPH HANNA MD

Neurology

6,423

$1.13M

498
171 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 25%

$177
Average prescription price

Avg: $245

JOSE CASANOVA MD PHD

Neurology

6,120

$1.07M

491
221 are 65+

46%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$174
Average prescription price

Avg: $245

JAMES BAVIS MD

Neurology

5,596

$1.14M

583
408 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$203
Average prescription price

Avg: $245

DONALD FREIDENBERG DO

Neurology

5,387

$381K

398
360 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 25%

$71
Average prescription price

Avg: $245

VADAK RANGANATHAN MD

Neurology

5,207

$720K

260
80 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 2%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$138
Average prescription price

Avg: $245

JAY BERKE MD

Neurology

5,204

$1.8M

578
391 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 25%

$346
Average prescription price

Avg: $245

HALINA PRITULA M.D.

Neurology

4,640

$453K

440
267 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 25%

$98
Average prescription price

Avg: $245

ASHRAF NASSEF MD

Neurology

4,602

$463K

342
96 are 65+

35%
patients receiving schedule two controlled substances

Avg: 3%

40%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$101
Average prescription price

Avg: $245

DEEPAK RAHEJA MD

Neurology

4,582

$1.07M

272
64 are 65+

24%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 25%

$235
Average prescription price

Avg: $245

BAHMAN SHARIF M.D.

Neurology

4,369

$441K

373
327 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$101
Average prescription price

Avg: $245

COLIN ZADIKOFF MD

Neurology

4,284

$871K

404
253 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$203
Average prescription price

Avg: $245

PRASAD KANNEGANTI MD

Neurology

4,101

$1M

404
259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 25%

$245
Average prescription price

Avg: $245

LAWRENCE ELMER M.D.

Neurology

3,987

$880K

400
336 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$221
Average prescription price

Avg: $245

GURMEET SINGH MD

Neurology

3,849

$482K

486
323 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 25%

$125
Average prescription price

Avg: $245

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank